Literature DB >> 21378356

Gastric cancer in a pregnant woman presenting with low back pain and bilateral erythematous breast hypertrophy mimicking primary inflammatory breast carcinoma.

Vincenzo Dario Mandato1, Debora Pirillo, Maria Carolina Gelli, Maurizio Cavina, Giovanni Battista La Sala.   

Abstract

This report describes the first case of a pregnant woman presenting low-back pain and breast pain associated with bilateral erythematous breast hypertrophy, proving to be the result of metastatic disease from a gastric carcinoma. A 30-year-old pregnant woman was admitted complaining of persistent severe low back pain, breast pain and concomitant bilateral erythematous breast hypertrophy, mimicking primary inflammatory breast carcinoma. During the caesarean section, widespread disease was found and finally metastatic gastric cancer was detected. Pregnant women with gastric cancer may present symptoms that are considered common during pregnancy. Common symptoms that present warning characteristics, such as the persistent severe pain observed in the presented case, should be carefully investigated as they may be the only warning signs and symptoms of rare ominous conditions such as gastric cancer.

Entities:  

Mesh:

Year:  2011        PMID: 21378356

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Cutaneous Metastasis of Gastric Cancer Mimicking Primary Inflammatory Breast Cancer.

Authors:  Yoon Seob Kim; Ji Hyun Lee; Young Min Park; Jun Young Lee
Journal:  Ann Dermatol       Date:  2015-12-07       Impact factor: 1.444

2.  Pregnancy and gastric cancer: diagnostic and treatment dilemma.

Authors:  Nawar Hussain; Navaneethakrishnan Selvakumari; Frances Afadapa; Olubusola Amu
Journal:  BMJ Case Rep       Date:  2018-06-23

Review 3.  Advanced gastrointestinal carcinoma with massive ascites and hydrothorax during pregnancy: A case report and review of the literature.

Authors:  Wenfeng Ye; Yanhong Tang; Changfang Yao; Junyu Shi; Yongjuan Xu; Jingting Jiang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.